19 General introduction Endoscopic Surgery (EAES) consensus on Indocyanine Green (ICG) fluorescence-guided surgery. Surg Endosc 2023, 37:1629-48. [23] Heeman W, Steenbergen W, van Dam G, Boerma EC: Clinical applications of laser speckle contrast imaging: a review. J Biomed Opt 2019, 24:1-11. [24] Heeman W, Wildeboer ACL, Al-Taher M, Calon JEM, Stassen LPS, Diana M, Derikx JPM, van Dam GM, Boerma EC, Bouvy ND: Experimental evaluation of laparoscopic laser speckle contrast imaging to visualize perfusion deficits during intestinal surgery. Surg Endosc 2023, 37:950-7. [25] Kojima S, Sakamoto T, Nagai Y, Matsui Y, Nambu K, Masamune K: Laser Speckle Contrast Imaging for Intraoperative Quantitative Assessment of Intestinal Blood Perfusion During Colorectal Surgery: A Prospective Pilot Study. Surg Innov 2019, 26:293-301. [26] Den Dulk M, Marijnen C, Collette L, Putter H, Påhlman L, Folkesson J, Bosset J-F, Rödel C, Bujko K, Van De Velde C: Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Journal of British Surgery 2009, 96:1066-75. [27] Wang S, Liu J, Wang S, Zhao H, Ge S, Wang W: Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis. World J Surg 2017, 41:277-84. [28] Bao QR, Pellino G, Spolverato G, Restivo A, Deidda S, Capelli G, Ruffolo C, Bianco F, Cuicchi D, Jovine E, Lombardi R, Belluco C, Amato A, La Torre F, Asteria C, Infantino A, Contardo T, Del Bianco P, Delrio P, Pucciarelli S: The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for midlow rectal cancer: extended follow-up of a randomised controlled trial. International Journal of Colorectal Disease 2022, 37:1689-98. [29] Ma L, Pang X, Ji G, Sun H, Fan Q, Ma C: The impact of anastomotic leakage on oncology after curative anterior resection for rectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2020, 99:e22139. [30] Bashir Mohamed K, Hansen CH, Krarup PM, Fransgård T, Madsen MT, Gögenur I: The impact of anastomotic leakage on recurrence and longterm survival in patients with colonic cancer: A systematic review and meta-analysis. Eur J Surg Oncol 2020, 46:439-47. [31] Koedam TW, Bootsma BT, Deijen CL, van de Brug T, Kazemier G, Cuesta MA, Fürst A, Lacy AM, Haglind E, Tuynman JB: Oncological outcomes after anastomotic leakage after surgery for colon or rectal cancer: increased risk of local recurrence. Annals of surgery 2022, 275:e420e7. [32] Arron MNN, Greijdanus NG, Bastiaans S, Vissers PAJ, Verhoeven RHA, Ten Broek RPG, Verheul HMW, Tanis PJ, van Goor H, de Wilt JHW: Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study. Ann Surg 2022, 276:882-9. [33] Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH: Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res 2017, 9:259-66. [34] Bakkers C, Lurvink RJ, Rijken A, Nienhuijs SW, Kok NF, Creemers GJ, Verhoef C, Lemmens VE, van Erning FN, De Hingh IH: Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study. Ann Surg Oncol 2021, 28:9073-83. [35] Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH: Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J Gastroenterol 2012, 18:5489-94. [36] Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP: Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006, 243:212-22. [37] Maggiori L, Elias D: Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol 2010, 36:599-603. [38] Jayne DG, Fook S, Loi C, Seow-Choen F: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002, 89:1545-50. [39] Simkens GA, Wintjens A, Rovers KP, Nienhuijs SW, de Hingh IH: Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC. Cancer Manag Res 2021, 13:5239-49. [40] Lurvink RJ, Rovers KP, Nienhuijs SW, Creemers GJ, Burger JWA, de Hingh IHJ: Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review. J Gastrointest Oncol 2021, 12:S242-s58. [41] Wintjens A, Liu H, Fransen PKH, Lenaerts K, van Almen GC, Gijbels MJ, Hadfoune M, Boonen BTC, Lieuwes NG, Biemans R, Dubois LJ, Dankers PYW, de Hingh I, Bouvy ND: Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a 1
RkJQdWJsaXNoZXIy MTk4NDMw